DISK DIFFUSION TESTING OF SUSCEPTIBILITY OF MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONEI TO ANTIBACTERIAL

被引:113
作者
WALLACE, RJ
DALOVISIO, JR
PANKEY, GA
机构
[1] BAYLOR UNIV,COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030
[2] ALTON OCHSNER MED FDN & OCHSNER CLIN,DEPT INTERNAL MED,INFECT DIS SECT,NEW ORLEANS,LA 70121
关键词
D O I
10.1128/AAC.16.5.611
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although recent studies have suggested that some antibacterial agents have good activity against the rapidly growing mycobacteria Mycobacterium fortuitum and Mycobacterium chelonei, an easily applicable method for susceptibility testing of clinical isolates is not yet available. We evaluated a disk diffusion method with Mueller-Hinton agar and 48-h readings with 59 strains of M. fortuitum and 11 strains of M. chelonei and compared the result to agar dilution susceptibilities for nine antimicrobial agents. All isolates were susceptible to 16 μg of amikacin or kanamycin per ml with minimum zone diameters of 14 and 18 mm, respectively. Amikacin inhibited 100% of isolates of M. fortuitum at 2 μg/ml, whereas 10 of 11 (91%) of M. chelonei strains had minimum inhibitory concentrations of 4.0 μg/ml or greater. Doxycycline and minocycline had almost identical activities, inhibiting 44% of strains at 4.0 μg/ml, and both allowed easy differentiation between susceptible and resistant strains by disk diffusion. Although most isolates of M. chelonei grew better on 7H10 agar, this media gave two- to eight-fold higher minimum inhibitory concentrations than were obtained with Mueller-Hinton agar. Disk diffusion susceptibility testing appears to be a simple and reliable means of predicting susceptibility results for M. fortuitum and most isolates of M. chelonei by the agar dilution method.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 8 条
[1]  
AWE RJ, 1973, AM REV RESPIR DIS, V108, P1230
[2]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONEI TO AMIKACIN [J].
DALOVISIO, JR ;
PANKEY, GA .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (03) :318-321
[3]  
GARCIARODRIGUEZ JA, 1978, TUBERCLE, V59, P277, DOI 10.1016/0041-3879(78)90005-3
[4]  
GARROD LP, 1971, ANTIBIOTICS CHEMOTHE, P476
[5]   IN-VITRO ACTIVITY OF ERYTHROMYCIN AGAINST ATYPICAL MYCOBACTERIA [J].
MOLAVI, A ;
WEINSTEIN, L .
JOURNAL OF INFECTIOUS DISEASES, 1971, 123 (02) :216-+
[6]   SUSCEPTIBILITY OF ORGANISMS IN MYCOBACTERIUM-FORTUITUM COMPLEX TO ANTITUBERCULOUS AND OTHER ANTIMICROBIAL AGENTS [J].
SANDERS, WE ;
HARTWIG, EC ;
SCHNEIDER, NJ ;
CACCIATORE, R ;
VALDEZ, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (02) :295-297
[7]   ANTI-MICROBIAL SUSCEPTIBILITY TESTING OF MYCOBACTERIUM-FORTUITUM COMPLEX [J].
WELCH, DF ;
KELLY, MT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (06) :754-757
[8]  
WICHELHAUSEN RH, 1965, 24 T RES C PULM DIS, P56